Regression analysis on symptoms reported by patients diagnosed with COVID-19
| Clinical symptom | People with confirmed infection (seropositive, any RT-qPCR result) (N=22) | People with acute disease (RT-qPCR reactive and seropositive) (N=15) | ||||
| OR | 95% CI | P value | OR | 95% CI | P value | |
| Change in taste | 6.02 | (1.02 to 35.51) | 0.047 | 571.72 | (1.92 to 170 629.2) | 0.029 |
| Nausea/vomiting | 4.42 | (0.748 to 26.09) | 0.101 | 370.11 | (2.71 to 50 429.42) | 0.018 |
| Sore throat | 0.36 | (0.067 to 1.93) | 0.233 | 0.002 | (0.000006 to 0.74) | 0.039 |
| Myalgia | 1.15 | (0.24 to 5.51) | 0.865 | 121.82 | (1.52 to 9749.08) | 0.032 |
| Breathlessness | 6.90 | (0.96 to 49.40) | 0.054 | 134.46 | (1.02 to 17 796.87) | 0.049 |
| Change in smell | 0.77 | (0.098 to 6.15) | 0.811 | 0.37 | (0.008 to 15.87) | 0.607 |
| Fever | 2.97 | (0.44 to 20.35) | 0.266 | 1.44 | (0.057 to 36.66) | 0.825 |
| Cough | 0.12 | (0.014 to 1.03) | 0.053 | 0.011 | (0.00008 to 1.42) | 0.069 |
Symptoms associated with confirmed SARS-CoV-2 infection (antibody confirmed positive, irrespective of RT-qPCR result) among 22 patients and with acute infection (RT-qPCR reactive, antibody confirmed positive) among 15 patients, respectively.
RT-qPCR, real-time reverse transcriptase-quantitative PCR.